BioVie Inc. (BIVI) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by BioVie Inc. on August 20, 2024. The filing addresses a corporate governance event regarding the company's listing status on The Nasdaq Stock Market, LLC.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document focuses exclusively on regulatory compliance status.
Material Changes
The primary material event reported is the resolution of a listing deficiency:
- Prior Status: On April 19, 2024, the company received notice from Nasdaq that its Class A common stock bid price had closed below the $1.00 minimum requirement for 30 consecutive business days.
- Current Status: On August 20, 2024, Nasdaq notified the company that it has regained compliance with the Bid Price Rule.
- Compliance Details: The stock closed at or above $1.00 per share for 10 consecutive business days between August 6, 2024, and August 19, 2024.
Outlook, Risks, and Management Commentary
Management stated that the company will "diligently work to continue to adhere to Nasdaq's listing standards." No new risks, contingencies, or unusual items were disclosed in this specific filing beyond the previously noted listing deficiency which has now been resolved.
Investor Verification Checklist
- Verify the current trading price of BIVI to ensure it remains above the $1.00 threshold to avoid future delisting notices.
- Review the April 19, 2024 Form 8-K for the initial details of the non-compliance notice.
- Monitor upcoming quarterly reports (10-Q) for financial performance data, as this 8-K contains no financial metrics.